BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announces that the
CERAMENT G has been approved for TPT for the indication bone infection, under the alternative pathway for devices that have received both breakthrough device designation and marketing authorization by the
The TPT payment is intended to reimburse hospitals and ambulatory surgical centers for the incremental cost of new and innovative technologies such as CERAMENT G in the outpatient setting.
CMS has previously granted CERAMENT G with the New Technology Add-on Payment (NTAP), which provides additional payment in the hospital inpatient setting.
© Modular Finance, source